SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-20-282726
Filing Date
2020-10-30
Accepted
2020-10-30 17:00:52
Documents
2
Group Members
ADAM S. HOROWITZ REVOCABLE TRUSTHOROWITZ MANAGEMENT, INC.JASON E. TESTER

Document Format Files

Seq Description Document Type Size
1 SC 13D d15767dsc13d.htm SC 13D 99876
2 EX-99.A d15767dex99a.htm EX-99.A 6831
  Complete submission text file 0001193125-20-282726.txt   108319
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Subject) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91774 | Film No.: 201278056
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 5030 CAMPUS DRIVE, SUITE A NEWPORT BEACH CA 92660
Business Address 5030 CAMPUS DRIVE, SUITE A NEWPORT BEACH CA 92660 (949) 831-5158
Horowitz Limited Partnership VIII (Filed by) CIK: 0001827839 (see all company filings)

IRS No.: 465761836 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D